Brussels, 07/12/2012 (Agence Europe) - In a ruling published on 6 December (Case C-457/10 P), the European Court of Justice rejected the appeal by pharmaceutical giant AstraZeneca (AZ) against General Court ruling T-321/05 (see EUROPE 10172) ruling that AstraZeneca had abused its dominant position by preventing the marketing of generic products replicating its ulcer treatment medicine Losec. On 15 June 2005, the Commission imposed a fine of €60 million on AstraZeneca AB and AstraZeneca plc...